Systematizing the genomic order and relatedness in the open reading frames (ORFs) of the coronaviruses.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
08 2021
Historique:
received: 29 08 2020
revised: 05 04 2021
accepted: 07 04 2021
pubmed: 14 4 2021
medline: 10 7 2021
entrez: 13 4 2021
Statut: ppublish

Résumé

The coronaviruses (CoVs), including SARS-CoV-2, the agent of the ongoing deadly CoVID-19 pandemic (Coronavirus disease-2019), represent a highly complex and diverse class of RNA viruses with large genomes, complex gene repertoire, and intricate transcriptional and translational mechanisms. The 3'-terminal one-third of the genome encodes four structural proteins, namely spike, envelope, membrane, and nucleocapsid, interspersed with genes for accessory proteins that are largely nonstructural and called 'open reading frame' (ORF) proteins with alphanumerical designations, but not in a consistent or sequential order. Here, I report a comparative study of these ORF proteins, mainly encoded in two gene clusters, i.e. between the Spike and the Envelope genes, and between the Membrane and the Nucleocapsid genes. For brevity and focus, a greater emphasis was placed on the first cluster, collectively designated as the 'orf3 region' for ease of referral. Overall, an apparently diverse set of ORFs, such as ORF3a, ORF3b, ORF3c, ORF3d, ORF4 and ORF5, but not necessarily numbered in that order on all CoV genomes, were analyzed along with other ORFs. Unexpectedly, the gene order or naming of the ORFs were never fully conserved even within the members of one Genus. These studies also unraveled hitherto unrecognized orf genes in alternative translational frames, encoding potentially novel polypeptides as well as some that are highly similar to known ORFs. Finally, several options of an inclusive and systematic numbering are proposed not only for the orf3 region but also for the other orf genes in the viral genome in an effort to regularize the apparently confusing names and orders. Regardless of the ultimate acceptability of one system over the others, this treatise is hoped to initiate an informed discourse in this area.

Identifiants

pubmed: 33848683
pii: S1567-1348(21)00155-6
doi: 10.1016/j.meegid.2021.104858
pmc: PMC8053407
pii:
doi:

Substances chimiques

Viral Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104858

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Références

Virol J. 2017 Nov 6;14(1):215
pubmed: 29110727
J Gen Virol. 2008 Aug;89(Pt 8):1960-1969
pubmed: 18632968
Curr Top Microbiol Immunol. 2013;372:173-91
pubmed: 24362690
Virology. 1992 Feb;186(2):676-83
pubmed: 1310191
J Virol. 1997 Aug;71(8):6183-90
pubmed: 9223514
J Virol. 2007 Feb;81(4):1786-95
pubmed: 17151097
FEBS J. 2021 Feb;288(3):756-785
pubmed: 32542989
J Clin Med. 2020 Apr 24;9(4):
pubmed: 32344679
Virology. 2003 Jun 20;311(1):16-27
pubmed: 12832199
J Virol. 2007 Jan;81(1):20-9
pubmed: 16928755
J Gen Virol. 2014 Apr;95(Pt 4):874-882
pubmed: 24443473
Biomed J. 2020 Aug;43(4):328-333
pubmed: 32387617
J Virol. 2005 Dec;79(23):14909-22
pubmed: 16282490
PLoS Pathog. 2005 Dec;1(4):e39
pubmed: 16341254
Curr Opin Plant Biol. 2017 Apr;36:129-134
pubmed: 28327435
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Pharmacol Ther. 1991;51(1):47-70
pubmed: 1771177
Science. 2003 Oct 10;302(5643):276-8
pubmed: 12958366
Am J Respir Cell Mol Biol. 2007 Jul;37(1):9-19
pubmed: 17413032
J Virol. 2012 Apr;86(7):3995-4008
pubmed: 22278237
Protein Cell. 2013 Dec;4(12):951-61
pubmed: 24318862
Science. 2004 Mar 12;303(5664):1666-9
pubmed: 14752165
J Virol. 2013 Nov;87(22):12489-95
pubmed: 24027320
J Virol. 2009 Jul;83(13):6631-40
pubmed: 19403678
J Gen Virol. 2005 Jul;86(Pt 7):1921-1930
pubmed: 15958670
Antiviral Res. 2013 Oct;100(1):246-54
pubmed: 23994189
Virology. 2004 Nov 10;329(1):11-7
pubmed: 15476870
J Virol. 2007 May;81(10):5423-6
pubmed: 17344286
J Virol. 2014 Apr;88(8):4251-64
pubmed: 24478444
Adv Virus Res. 2006;66:193-292
pubmed: 16877062
J Virol. 2005 Feb;79(4):2079-86
pubmed: 15681410
Cell Death Dis. 2018 Sep 5;9(9):904
pubmed: 30185776
Arch Virol. 1999;144(4):763-70
pubmed: 10365166
Virus Res. 2008 Apr;133(1):113-21
pubmed: 18045721
Virology. 2005 Feb 20;332(2):498-510
pubmed: 15680415
J Virol. 2007 Jan;81(2):548-57
pubmed: 17108024
J Virol. 2006 Jan;80(1):210-7
pubmed: 16352545
J Virol. 2014 Jan;88(2):1318-31
pubmed: 24227844
J Gen Virol. 2014 Feb;95(Pt 2):393-402
pubmed: 24189622
Virus Res. 2006 Dec;122(1-2):20-7
pubmed: 16965829
J Virol. 2008 May;82(10):5084-8
pubmed: 18353961
J Virol. 2004 Apr;78(8):3863-71
pubmed: 15047802
J Infect Dis. 2020 Aug 4;222(5):722-725
pubmed: 32559285
Science. 2020 May 15;368(6492):779-782
pubmed: 32277040
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
J Virol. 2019 Oct 15;93(21):
pubmed: 31375588
Sci Rep. 2016 Dec 01;6:38139
pubmed: 27905537
Virology. 1991 Dec;185(2):911-7
pubmed: 1962461
Virology. 1997 Aug 18;235(1):1-9
pubmed: 9300032
Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S203-7
pubmed: 16378047
Mol Biol Evol. 2017 Sep 1;34(9):2422-2424
pubmed: 28472384
J Virol. 2006 Jan;80(1):296-305
pubmed: 16352554
Annu Rev Microbiol. 1997;51:151-78
pubmed: 9343347
J Virol. 2010 Jan;84(2):1097-109
pubmed: 19889773
Virology. 1992 Jun;188(2):417-28
pubmed: 1316668
Comput Struct Biotechnol J. 2020 Jul 17;18:1884-1890
pubmed: 32765822
J Infect Dis. 2004 Apr 1;189(7):1164-7
pubmed: 15031783
J Virol. 2010 May;84(9):4330-40
pubmed: 20164235
J Virol. 2014 May;88(9):4866-76
pubmed: 24522921
Virol J. 2005 Aug 17;2:66
pubmed: 16107218
PLoS Comput Biol. 2015 Oct 06;11(10):e1004408
pubmed: 26439115

Auteurs

Sailen Barik (S)

3780 Pelham Drive, Mobile, AL 36619, USA. Electronic address: barikfamily@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH